What is the place of carboplatin in paediatric oncology?
- 31 December 1994
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (2), 194-201
- https://doi.org/10.1016/0959-8049(94)90086-8
Abstract
No abstract availableThis publication has 71 references indexed in Scilit:
- RetinoblastomaOncologie, 2006
- Pilot study of high-dose vincristine, etoposide, carboplatin and melphalan with autologous bone marrow rescue in advanced neuroblastomaEuropean Journal Of Cancer, 1992
- Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastomaEuropean Journal Of Cancer, 1992
- Secondary acute non‐lymphoblastic leukemia in two children following treatment with a cis‐diamminedichloroplatinum‐II‐based regimen for osteosarcomaMedical and Pediatric Oncology, 1992
- Dose‐dependent cytotoxic and mutagenic effects of antineoplastic alkylating agents on human lymphoblastoid cellsEnvironmental and Molecular Mutagenesis, 1991
- Resistance to platinum compounds: Mechanisms and beyondEuropean Journal of Cancer and Clinical Oncology, 1989
- Clinical Pharmacokinetics of CarboplatinThe Journal of Clinical Pharmacology, 1988
- Decreased cisplatin uptake by resistant L1210 leukemia cellsCancer Letters, 1987
- Phase I clinical trial and pharmacokinetics of carboplatin (nsc 241240) by single monthly 30-minute infusionCancer, 1986
- Effective cisplatin (DDP) based chemotherapy in the treatment of hepatoblastomaMedical and Pediatric Oncology, 1985